Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

208 projects found matching your search criteria :

  1. Effect of aliskiren, a renin inhibitor, on the anticonvulsant activity of antiepileptic drugs in three seizure tests in ...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: dr Krzysztof Łukawski

    Instytut Medycyny Wsi im. Witolda Chodźki

  2. Chiral cores/monomers of drugs and conducting polymers: From calculations to experimental characteristics

    Call: OPUS 5 , Panel: ST5

    Principal investigator: prof. Jan Czesław Dobrowolski

    Instytut Chemii i Techniki Jądrowej

  3. The studies on pharmacomodulation of oleanolic acid - new biogenic triterpene heterodimers

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: prof. Lucjusz Zaprutko

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  4. Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: Katarzyna Karolina Kamińska

    Instytut Farmakologii PAN

  5. Design of enzyme systems for the study of chiral drugs with the use of superparamagnetic nanoparticles as carriers for b...

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: dr Tomasz Siódmiak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

  6. Study on influence of local anaesthetics on model membranes of nerve cells, mitochondria and erythrocyrtes, with use of ...

    Call: PRELUDIUM 5 , Panel: ST5

    Principal investigator: Justyna Aleksandra Mildner

    Uniwersytet Jagielloński, Wydział Chemii

  7. The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants.

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii PAN

  8. Tailored lipidic mesophases in drug delivery system developement

    Call: SONATA 5 , Panel: ST5

    Principal investigator: dr Ewa Nazaruk

    Uniwersytet Warszawski, Wydział Chemii

  9. Transcription factor MeCP2 as an intracellular object of study on the mechanism of depression and as a potential pharmac...

    Call: SONATA 5 , Panel: NZ7

    Principal investigator: dr Magdalena Jolanta Sowa-Kućma

    Instytut Farmakologii PAN

  10. Bacterial degradation of non-steroidal anti-inflammatory drugs

    Call: OPUS 5 , Panel: NZ9

    Principal investigator: dr hab. Danuta Barbara Wojcieszyńska

    UNIWERSYTET ŚLĄSKI, Wydział Biologii i Ochrony Środowiska; Wydział Biologii i Ochrony Środowiska

  11. Modeling of the dry electrostatic coating process of enteric drugs in a modified Wurster apparatus

    Call: OPUS 5 , Panel: ST8

    Principal investigator: dr Wojciech Jarosław Ludwig

    Politechnika Wrocławska, Wydział Chemiczny

  12. Research on influence of antidepressant drugs on serum and brain levels of neurotrophins in rats, affected by the time d...

    Call: OPUS 4 , Panel: NZ4

    Principal investigator: dr Maciej Sławomir Kuśmider

    Instytut Farmakologii PAN

  13. Synthesis and anticancer activity of octahydropyrazin[2, 1-a:5,4-a']diisoquinoline deratives

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: prof. Krzysztof Bogusław Bielawski

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  14. PAMAM G4 and G3,5 dendrimers as potential carriers of oncological drugs

    Call: OPUS 4 , Panel: ST4

    Principal investigator: prof. Henryk Czesław Piekarski

    Uniwersytet Łódzki, Wydział Chemii

  15. Electrochemical detection of phycotropic substances based on DNA intercalation

    Call: PRELUDIUM 4 , Panel: ST4

    Principal investigator: dr Joanna Maria Jankowska-Śliwińska

    Instytut Biocybernetyki i Inżynierii Biomedycznej im. Macieja Nałęcza PAN

  16. Examine the importance of intracellular pathways in the action of opioids in microglial cells in vitro

    Call: PRELUDIUM 4 , Panel: NZ3

    Principal investigator: Katarzyna Popiołek-Barczyk

    Instytut Farmakologii PAN

  17. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Call: MAESTRO 3 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii PAN

  18. The influence of some selected antiepileptic drugs in combination with arachinodyl-2-chlorethylamide, a selective cannab...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr Marta Andres-Mach

    Instytut Medycyny Wsi im. Witolda Chodźki

  19. The examination of isothiocyanates influence on cytotoxic and cytostatic effects of 5-fluorouracil in cancer cell lines ...

    Call: PRELUDIUM 3 , Panel: NZ5

    Principal investigator: Małgorzata Milczarek

    Narodowy Instytut Leków

  20. The study of the role of mGluR8 in cancer cells - a potential target for new antitumor strategies

    Call: OPUS 3 , Panel: NZ3

    Principal investigator: dr Danuta Jantas

    Instytut Farmakologii PAN

  21. The role of CRH-BP protein in the regulation of the hypothalamic-pituitary-adrenal axis after antidepressant drugs treat...

    Call: OPUS 3 , Panel: NZ4

    Principal investigator: dr Joanna Solich

    Instytut Farmakologii PAN

  22. Computational methods for identyfiing drug resistance associated mutations in bacterial strains

    Call: PRELUDIUM 3 , Panel: ST6

    Principal investigator: Michał Jan Woźniak

    Uniwersytet Warszawski

  23. Role of the endocannabionoid system in the pathogenesis of depression and in the mechanism of action of antidepressant d...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: prof. Małgorzata Maria Filip

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  24. Evaluation of the role of subpopulations of T lymphocytes (Treg: CD4+CD25+, CD4+CD25- i Teff: Th2) in depression using p...

    Call: OPUS 3 , Panel: NZ4

    Principal investigator: dr Sylwia Kędracka-Krok

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  25. Interactions between biologically active phytocompounds present in the fodder and selected therapeuticals used in the th...

    Call: SONATA 3 , Panel: NZ9

    Principal investigator: dr hab. Marta Mendel

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  26. Drug Design: Chirality Measures as QSAR descriptors.

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: Piotr Jakub Lipiński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  27. New benzo[b]furane and dicarboximide derivatives with anticancer activity- studies on the mechanism of action in human c...

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: Karolina Królewska

    Centrum Badań Molekularnych i Makromolekularnych PAN

  28. Evaluation of the ability of human dendritic cells generated in the environment of cyclosporine A i rapamycin to induce ...

    Call: PRELUDIUM 3 , Panel: NZ6

    Principal investigator: Maja Katarzyna Machcińska

    Uniwersytet Warszawski, Wydział Biologii

  29. Role of autophagy in chemoresistance of glioblastoma stem-like cells

    Call: OPUS 2 , Panel: NZ3

    Principal investigator: dr Iwona Anna Ciechomska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  30. The importance of pharmacogenetic factors in the individualization of therapy using immunosuppressive drugs in kidney tr...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Anna Bogacz

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  31. Determining the potential effects of pharmaceuticals in the environment: an ecotoxicity evaluation of selected veterinar...

    Call: OPUS 2 , Panel: NZ8

    Principal investigator: prof. Piotr Stepnowski

    Uniwersytet Gdański, Wydział Chemii

  32. Removal of antibacterial agents from the aquatic environment

    Call: PRELUDIUM 2 , Panel: ST8

    Principal investigator: dr Justyna Jadwiga Ziemiańska-Błaszczyk

    Instytut Medycyny Pracy i Zdrowia Środowiskowego

  33. Supramolecular complexes of cucurbiturils as crystalline functional materials: synthesis, studies of structure and prope...

    Call: SONATA 2 , Panel: ST5

    Principal investigator: dr Oksana Danylyuk

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

  34. Analysis of the use of medicines containing psychotropic substances of the IV-P group, emphasis on anxiolytic and hypnot...

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Anna Patrycja Gołda

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  35. Neuroplasticity regulation by alternative gene transcription

    Call: SONATA 2 , Panel: NZ3

    Principal investigator: dr Michał Korostyński

    Instytut Farmakologii PAN

  36. The influence of tunicamycin analogues and mimetics on hepatitis C virus (HCV) propagation.

    Call: PRELUDIUM 2 , Panel: NZ6

    Principal investigator: dr Ewelina Król

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  37. Role of mitochondrial DNA damage and repair in the resistance of BCR/ABL-expressing cells to imatinib

    Call: OPUS 2 , Panel: NZ2

    Principal investigator: prof. Janusz Błasiak

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  38. Classification of treatment processes of wastewater containing antimicrobial drugs based on changes in their micriobial ...

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr hab. Wojciech Baran

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu

  39. UPLC-MS/MS for methods development for determination of antioxidants and a new generation drugs used in cardiology

    Call: PRELUDIUM 2 , Panel: ST4

    Principal investigator: dr Sylwia Magiera

    Politechnika Śląska, Wydział Chemiczny

  40. The role of GPR39 receptor in the mechanism of antidepressant action

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  41. Metabolic stability and inhibition of P450 enzymes in combination with chemometric techniques as a tool for selection of...

    Call: OPUS 2 , Panel: NZ1

    Principal investigator: prof. Tomasz Bączek

    Gdański Uniwersytet Medyczny, Wydział Farmcautyczny z Oddziałem Medycyny Laboratoryjnej

  42. Evaluation of contamination of Vistula River near Warsaw by pharmaceuticaly active compounds and metabolites

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: prof. Grzegorz Leszek Nałęcz-Jawecki

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  43. Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi...

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: dr hab. Joanna Gabriela Mika

    Instytut Farmakologii PAN

  44. Advanced techniques of circular dichroism as a valuable tool in structural analysis of pharmacologically important compo...

    Call: PRELUDIUM 2 , Panel: ST4

    Principal investigator: dr Marcin Janusz Górecki

    Instytut Chemii Organicznej Polska Akademia Nauk

  45. Clinical efficacy of pharmacotherapy with antihistaminics and leukotriene antagonists and the therapy impact on cyclooxy...

    Call: PRELUDIUM 1 , Panel: NZ5

    Principal investigator: Paulina Maria Korczyńska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  46. Characterization of melanospheres derived from clinical melanoma specimens in terms of their capability to recapitulate ...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: prof. Małgorzata Ewa Czyż

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  47. A new gereration of anticancer pronucleotides

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: prof. Jacek Antoni Stawiński

    Instytut Chemii Bioorganicznej PAN

  48. Charge Density Studies of Selected Pharmaceutical Substances - Towards Energy of Interations with Macromolecules

    Call: PRELUDIUM 1 , Panel: ST4

    Principal investigator: Maura Dagmara Malińska

    Uniwersytet Warszawski, Wydział Chemii

  49. Atypical antipsychotic drugs effects on pro-and antioxidative processes, and apoptosis - a study in blood cells, plasma,...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Anna Dietrich-Muszalska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  50. Identification and targeting molecular drug resistance mechanisms in adult B-cell acute lymphoblastic leukemia

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Przemysław Juszczyński

    Instytut Hematologii i Transfuzjologii